Charles River Laboratories International (CRL) Leases (2019 - 2025)
Charles River Laboratories International (CRL) has 7 years of Leases data on record, last reported at $361.4 million in Q4 2025.
- For Q4 2025, Leases rose 1150.57% year-over-year to $361.4 million; the TTM value through Dec 2025 reached $361.4 million, up 1150.57%, while the annual FY2025 figure was $361.4 million, 1150.57% up from the prior year.
- Leases reached $361.4 million in Q4 2025 per CRL's latest filing, down from $374.3 million in the prior quarter.
- Across five years, Leases topped out at $408.5 million in Q2 2023 and bottomed at $28.9 million in Q4 2024.
- Average Leases over 5 years is $339.4 million, with a median of $378.7 million recorded in 2022.
- Peak YoY movement for Leases: tumbled 92.67% in 2024, then soared 1150.57% in 2025.
- A 5-year view of Leases shows it stood at $292.9 million in 2021, then soared by 33.73% to $391.8 million in 2022, then rose by 0.58% to $394.0 million in 2023, then crashed by 92.67% to $28.9 million in 2024, then skyrocketed by 1150.57% to $361.4 million in 2025.
- Per Business Quant database, its latest 3 readings for Leases were $361.4 million in Q4 2025, $374.3 million in Q3 2025, and $385.8 million in Q2 2025.